Potential neuroprotective biomolecules in ophthalmology.

Seyede Pegah Azarchehry Fatemeh Sanie-Jahromi

Published in: International ophthalmology (2020)

A broad range of drugs has been illustrated in the literature for treatment of neuro-ophthalmic diseases. A good classification of the most applied drugs in this field can help specialists to prescribe the best matched drug considering the stage and progression of disease. However, controlled clinical trials are needed for better evaluation of the effects of these products.

Keyphrases

clinical trial
systematic review
machine learning
deep learning
artificial intelligence
drug induced
emergency department
risk assessment
human health
cerebral ischemia
combination therapy
adverse drug
phase iii
double blind
electronic health record
placebo controlled